5030 J ournal of Medicinal Chemistry, 1996, Vol. 39, No. 26
Communications to the Editor
from a Hepatocellular Carcinoma. Nature 1988, 333, 669-672.
(e) Krust, A.; Kastner, P.; Petkovich, M.; Zelent, A.; Chambon,
P. A Third Human Retinoic Acid Receptor, hRARγ. Proc. Natl.
Acad. Sci. U.S.A. 1989, 86, 5310-5314.
(14) (a) J ohnson, A. T.; Klein, E. S.; Gillett, S. J .; Wang, L.; Song, T.
K.; Pino, M. E.; Chandraratna, R. A. S. Synthesis and Charac-
terization of a Highly Potent and Effective Antagonist of Retinoic
Acid Receptors. J . Med. Chem. 1995, 38, 4764-4767. (b) Eyrolles,
L.; Kagechiko, H.; Kawachi, E.; Fukasawa, H.; Iijima, T.;
Matsushima, Y.; Hashimoto, Y.; Shudo, K. Retinobenzoic Acids.
6. Retinoid Antagonists with a Heterocyclic Ring. J . Med. Chem.
1994, 37, 1508-1517. (c) Yoshimura, H.; Nagai, M.; Hibi, S.;
Kikuchi, K.; Abe, S.; Hida, T.; Higashi, S.; Hishinumura, I.;
Yamanaka, T. A Novel Type of Retinoic Acid Receptor Antago-
nist: Synthesis and Structure-Activity Relationships of Hetero-
cyclic Ring-Containing Benzoic Acid Derivatives. J . Med. Chem.
1995, 38, 3163-3173. (d) Lee, M.-O.; Dawson, M. I.; Picard, N.;
Hobbs, P. D.; Pfahl, M. A Novel Class of Retinoid Antagonist
and Their Mechanism of Action. J . Biol. Chem. 1996, 271,
11897-11903. (e) Apfel, C.; Bauer, F.; Crettaz, M.; Forni, L.;
Kamber, M.; Kaufmann, F.; LeMotte, P.; Pirson, W.; Klaus, M.
A Retinoic Acid Receptor R Antagonist Selectively Counteracts
Retinoic Acid Effects. Proc. Natl. Acad. Sci. U.S.A. 1992, 89,
7129-7133.
(15) Recently Chen et al. reported on the biological activity of two
RARâ specific agonists. Unfortunately the structures of these
compounds were not disclosed. As a result, a valid comparison
of their findings with those in this communication cannot be
made at this time. Chen, J .-Y.; Penco, S.; Ostrowski, J .; Bal-
aguer, P.; Pons, M.; Starrett, J . E., J r.; Reczek, P.; Chambon,
P.; Gronemeyer, H. RAR-specific Agonisist / Antagonists which
Dissociate Transactivation and AP1 Transrepression Inhibit
Anchorage-independent Cell Proliferation. EMBO J . 1995, 14,
1187-1197.
(16) J ohnson, A. T.; Klein, E. S.; Gillett, S. J .; Wang, L.; Song, T. K.;
Pino, M. E.; Chandraratna, R. A. S. Synthesis and Characteriza-
tion of a Highly Potent and Effective Antagonist of Retinoic Acid
Receptors. J . Med. Chem. 1995, 38, 4764-4767.
(17) Arcadi, A.; Burini, A.; Cacchi, S.; Delmastro, M.; Marinelli, F.;
Pietroni, B. The Palladium-Catalyzed Cross Coupling of Vinyl
and Aryl Triflates with 2-Furylzinc Chloride: An Efficient Route
to 2-Vinyl-and 2-Arylfurans. Synlett 1990, 47-48.
(18) Holt, D. A.; Levy, M. A.; Ladd, D. L.; Oh, H.-J .; Erb, J . M.;
Heaslip, J . I.; Brandt, M.; Metcalf, B. W. Steroidal A Ring Aryl
Carboxylic Acids: A New Class Of Steroid 5R-Reductase Inhibi-
tors. J . Med. Chem. 1990, 33, 937-942.
(19) Comins, D. L.; Dehghani, A. Pyridine-Derived Triflating Re-
agents: An Improved Preparation of Vinyl Triflates from Metallo
Enolates. Tetrahedron Lett. 1992, 33, 6299-6302.
(4) (a) Heyman, R. A.; Mangelsdorf, D. J .; Dyck, J . A.; Stein, R. B.;
Eichele, G.; Evans, R. M.; Thaller, C. 9-cis-Retinoic Acid is a
High Affinity Ligand for the Retinoid X Receptor. Cell 1992, 68,
397-406. (b) Levin, A. A.; Sturzenbecker, L. J .; Kazmer, S.;
Bosakowski, T.; Huselton, C.; Allenby, G.; Speck, J .; Kratzeisen,
C.; Rosenberger, M.; Lovey, A.; Grippo, J . F. 9-cis-Retinoic Acid
Stereoisomer Binds and Activates the Nuclear Receptor RXRR.
Nature 1992, 355, 359-361.
(5) Esgleyes-Ribot, T.; Chandraratna, R. A. S.; Lew-Kaya, D. A.;
Sefton, J .; Duvic, M. Response of Psoriasis to a New Topical
Retinoid, AGN 190168. J . Am. Acad. Dermatol. 1994, 30, 581-
590.
(6) Retinoids: Present and Future. Proceedings of a Symposium Held
at the 18th World Congress of Dermatology; Shalita, A. R.,
Fritsch, P. O., Eds.; Supplement to J . Am. Acad. Dermatol. 1992,
27, part 2.
(7) (a) Tallman, M. S.; Wiernick, P. H. Retinoids in Cancer Treat-
ment. J . Clin. Pharmacol. 1992, 32, 868-888. (b) Zhang, X.-K.;
Liu, Y.; Lee, M.-O. Retinoids Receptors in Human Lung Cancer
and Breast Cancer. Mutat. Res. 1996, 350, 267-277.
(8) Rees, J . The Molecular Biology of Retinoic Acid Receptors:
Orphan from Good Family Seeks Home. Br. J . Dermatol. 1992,
126, 97-104.
(9) Elder, J . T.; Fisher, G. J .; Zhang, Q.-Y.; Eisen, D.; Krust, A.;
Kastner, P.; Chambon, P.; Voorhees, J . J . Retinoic Acid Receptor
Gene Expression in Human Skin. J . Invest. Dermatol. 1991, 96,
425-433.
(10) Reczek, P. R.; Ostrowski, J .; Yu, K.-L.; Chen, S.; Hammer, L.;
Roalsvig, T.; Starrett, J . E., J r.; Driscoll, J . P.; Whiting, G.;
Spinazze, P. G.; Tramposch, K. M.; Mansuri, M. M. Role of
Retinoic Acid Receptor Gamma in the Rhino Mouse and Rabbit
Irritation Models of Retinoid Activity. Skin Pharmacol. 1995,
8, 292-299.
(11) (a) Dolle, P.; Ruberte, E.; Kastner, P.; Petkovich, M.; Stoner, C.
M.; Gudas, L. J .; Chambon, P.; Differential Expression of Genes
Encoding R, â and γ Retinoic Acid Receptors and CRABP in
Developing Limbs of the Mouse. Nature 1989, 342, 702-705.
(b) Ruberte, E.; Dolle’, P.; Krust, A.; Zelent, A.; Morris-Kay, G.;
Chambon, P. Specific Spatial and Temporal Distribution of
Retinoic Acid Receptor Gamma Transcripts During Mouse
Embryogenesis. Development 1990, 108, 213-222.
(12) (a) Chandraratna, R. A. S.; Gillett, S. J .; Song, T. K.; Attard, J .;
Vuligonda, S.; Garst, M. E.; Arefieg,, T.; Gil, D. W.; Wheeler, L.
Synthesis and Pharmacological Activity of Conformationally
Restricted, Acetylenic Retinoid Analogs. Bioorg. Med. Chem.
Lett. 1995, 5, 523-527. (b) Beard, R. L.; Gil, D. W.; Marler, D.
K.; Henry, E.; Colon, D. F.; Gillett, S. J .; Arefieg, T.; Breen, T.
S.; Krauss, H.; Davies, P. J . A.; Chandraratna, R. A. S.
Structural Basis for the Differential RXR & RAR Activity of
Stilbene Retinoid Analogs. Bioorg. Med. Chem. Lett. 1994, 4,
1447-1452. (c) Lehmann, J . M.; J ong, L.; Fanjul, A.; Cameron,
J . F.; Lu, X. P.; Haefner, P.; Dawson, M. I.; Pfahl, M. Retinoids
Selective for Retinoid X Receptor Response Pathways. Science
1992, 258, 1944-1946. (d) Boehm, M. F.; Zhang, L.; Badea, B.
A.; White, S. K.; Mais, D. E.; Berger, E.; Suto, C. M.; Goldman,
M. E.; Heyman, R. A. Synthesis and Structure-Activity Relation-
ships of Novel Retinod X Receptor-Selective Retinoids. J . Med.
Chem. 1994, 37, 2930-2941.
(20) (a) Heyman, R. A.; Mangelsdorf, D. J .; Dyck, J . A.; Stein, R. B.;
Eichele, G.; Evans, R. M.; Thaller, C. 9-Cis Retinoic Acid is a
High Affinity Ligand for the Retinoid X Receptor. Cell 1992, 68,
397-406. (b) Christensen, K.; Estes, P. A.; Onate, S. A.; Beck,
C. A.; DeMarzo, A.; et al. Characterization and Functional
Properties of the A and
B Forms of Human Progesterone
Receptors Synthesized in a Baculovirus System. Mol. Endocrinol.
1991, 5, 1755-1770. (c) Cheng, Y.-C.; Prussof, W. H. The
and the
Relationship Between the Inhibitory Constant KI
Concentration of Inhibitor which Causes 50% Inhibition (IC50
)
of an Enzymatic Reaction. Biochem. Pharmcol. 1973, 22, 3099-
3108.
(13) (a) Teng, M.; Duong, T. T.; Klein, E. S.; Pino, M. E.; Chan-
draratna, R. A. S. Identification of a Retinoic Acid Receptor R
Subtype Specific Agonist. J . Med. Chem. 1996, 39, 3035-3038.
(b) Charpentier, B.; Bernardon, J .-M.; Eustache, J .; Millois, C.;
Martin, B.; Michel, S.; Shroot, B. Synthesis, Structure-Activity
Relationships, and Biological Activities of Ligands Binding to
Retinoic Acid Receptor Subtypes. J . Med. Chem. 1995, 38, 4993-
5006. (c) Yu, K.-L.; Spinazze, P.; Ostrowski, J .; Currier, S. J .;
Pack, E. J .; Hammer, L.; Roalsvig, T.; Honeyman, J . A.;
Tortolani, D. R.; Reczek, P. R.; Mansuri, M. M.; Starrett, J . E.,
J r. Retinoic Acid Receptor â, γ-Selective Ligands: Synthesis and
Biolgical Activity of 6-Substituted 2-Naphthoic Acid Retinoids.
J . Med Chem. 1996, 39, 2411-2421. (d) Lehmann, J . M.;
Dawson, M. I.; Hobbs, P. D.; Husmann. M.; Pfahl, M. Identifica-
tion of Retinoids with Nuclear Receptor Subtype-selective Activi-
ties. Cancer Res. 1991, 51, 4804-4809. (e) Kagechika, H.;
Kawachi, E.; Hashimoto, Y.; Himi, T.; Shudo, K. Retinobenzoic
Acids. 1. Structure-Activity Relationships of Aromatic Amides
with Retinoidal Activity. J . Med. Chem. 1988, 31, 2182.
(21) Klein, E. S.; Pino, M. E.; J ohnson, A. T.; Davies, P. J . A.; Nagpal,
S.; Thacher, S. M.; Krasinski, G.; Chandraratna, R. A. S.
Identification and Functional Separation of Retinoic Acid Recep-
tor Neutral Antagonists and Inverse Agonists. J . Biol. Chem.
1996, 271, 22692-22696.
(22) Umesono, K.; Giguere, V.; Glass, C. K.; Rosenfeld, M. G.; Evans,
R. M. Retinoic Acid and Thyroid Hormone Induce Gene Expres-
sion Through a Common Responsive Element. Nature 1988, 336,
262-265.
(23) We have also found the C8 phenyl analog of compound 1 to
exhibit the same profile as 1 in the RAR transactivation assay,
though the efficacy at RARâ is somewhat lower.
J M960687R